These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 426822)

  • 1. Anti-inflammatory pyrazolo-steroids: potent glucocorticoids containing bulky A-ring substituents and no C3-carbonyl.
    Simons SS; Thompson EB; Johnson DF
    Biochem Biophys Res Commun; 1979 Feb; 86(3):792-800. PubMed ID: 426822
    [No Abstract]   [Full Text] [Related]  

  • 2. Glucocorticoid versus antiglucocorticoid activity: can a single functional group modification of glucocorticoid steroids always convey antiglucocorticoid activity?
    Lamontagne N; Mercier L; Pons M; Thompson EB; Simons SS
    Endocrinology; 1984 Jun; 114(6):2252-63. PubMed ID: 6547091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocorticoid agonist and antagonist activity of 17,21-acetonide steroids.
    Rousseau GG; Cambron P; Brasseur N; Marcotte L; Matton P; Schmit JP
    J Steroid Biochem; 1983 Mar; 18(3):237-44. PubMed ID: 6572290
    [No Abstract]   [Full Text] [Related]  

  • 4. Calmodulin antagonists competitively inhibit dexamethasone binding to the glucocorticoid receptor.
    Van Bohemen CG; Rousseau GG
    FEBS Lett; 1982 Jun; 143(1):21-5. PubMed ID: 7117519
    [No Abstract]   [Full Text] [Related]  

  • 5. Structure-activity relationships for glucocorticoids-I. Determination of receptor binding and biological activity.
    Rousseau GG; Schmit JP
    J Steroid Biochem; 1977 Sep; 8(9):911-9. PubMed ID: 199797
    [No Abstract]   [Full Text] [Related]  

  • 6. Fluorescent chemoaffinity labeling. Potential application of a new affinity labeling technique to glucocorticoid receptors.
    Simons SS; Thompson EB; Johnson DF
    Biochemistry; 1979 Oct; 18(22):4915-22. PubMed ID: 508723
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthesis and biological activity of some novel, chemically reactive glucocorticoids.
    Simons SS; Thompson EB; Merchlinsky MJ; Johnson DF
    J Steroid Biochem; 1980 Mar; 13(3):311-22. PubMed ID: 7392608
    [No Abstract]   [Full Text] [Related]  

  • 8. Structural requirements for the binding of dexamethasone to nuclear envelopes and plasma membranes.
    Roszak AW; Lefebvre YA; Howell GM; Codding PW
    J Steroid Biochem Mol Biol; 1990 Oct; 37(2):201-14. PubMed ID: 2268551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between chemical structure, receptor binding, and biological activity of some novel, highly active, 16 alpha, 17 alpha-acetal-substituted glucocorticoids.
    Dahlberg E; Thalén A; Brattsand R; Gustafsson JA; Johansson U; Roempke K; Saartok T
    Mol Pharmacol; 1984 Jan; 25(1):70-8. PubMed ID: 6708937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of steroids to mineralocorticoid receptors: implications for in vivo occupancy by glucocorticoids.
    Lan NC; Graham B; Bartter FC; Baxter JD
    J Clin Endocrinol Metab; 1982 Feb; 54(2):332-42. PubMed ID: 6274900
    [No Abstract]   [Full Text] [Related]  

  • 11. Synthesis of halogen-substituted pyridyl and pyrimidyl derivatives of [3,2-c]pyrazolo corticosteroids: strategies for the development of glucocorticoid receptor mediated imaging agents.
    Hoyte RM; Zhang JX; Lerum R; Oluyemi A; Persaud P; O'Connor C; Labaree DC; Hochberg RB
    J Med Chem; 2002 Nov; 45(24):5397-405. PubMed ID: 12431067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoid activity and structure activity relationships in a series of some novel 17 alpha-ether-substituted steroids: influence of 17 alpha-substituents.
    Hochhaus G; Druzgala P; Hochhaus R; Huang MJ; Bodor N
    Drug Des Discov; 1991 Dec; 8(2):117-25. PubMed ID: 1793774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of glucocorticoid-induced inhibition of prostaglandin synthesis.
    Russo-Marie F; Paing M; Duval D
    Agents Actions Suppl; 1979; (4):49-62. PubMed ID: 291312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iodinated and fluorinated steroid 2'-aryl-[3,2-c] pyrazoles as potential glucocorticoid receptor imaging agents.
    Hoyte RM; Labaree DC; Fede JM; Harris C; Hochberg RB
    Steroids; 1998 Nov; 63(11):595-602. PubMed ID: 9830686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Yb-glutathione-S-transferase as a major rat liver protein labeled with dexamethasone 21-methanesulfonate.
    Homma H; Listowsky I
    Proc Natl Acad Sci U S A; 1985 Nov; 82(21):7165-9. PubMed ID: 3864152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in the interaction of RU 486 and ketoconazole with the second binding site of the glucocorticoid receptor.
    Svec F
    Endocrinology; 1988 Oct; 123(4):1902-6. PubMed ID: 3416819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Submicromolar free calcium modulates dexamethasone binding to the glucocorticoid receptor.
    Rousseau GG; van Bohemen CG; Lareau S; Degelaen J
    Biochem Biophys Res Commun; 1982 May; 106(1):16-22. PubMed ID: 6808997
    [No Abstract]   [Full Text] [Related]  

  • 18. Expeditious synthesis of steroids containing a 2-methylsulfanyl-acetyl side chain as potential glucocorticoid receptor imaging agents.
    Wuest F; Carlson KE; Katzenellenbogen JA
    Steroids; 2008 Jan; 73(1):69-76. PubMed ID: 17942130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of the interaction of 1,4-dihydropyridine derivatives with glucocorticoid hormone receptors from the rat liver.
    Vaitkuviene A; Ulinskaite A; Meskys R; Duburs G; Klusa V; Liutkevicius E
    Pharmacol Rep; 2006; 58(4):551-8. PubMed ID: 16963802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melatonin and glucocorticoid hormones.
    Familari M; Funder JW
    Jpn J Exp Med; 1988 Apr; 58(2):73-7. PubMed ID: 3411792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.